Salmeterol xinafoate: an analysis of outcomes and cost-effectiveness using a primary care database

被引：5

作者：

Price, DB

Cargill, K

Wolfe, S

Darby, H

机构：

[1] Thorpewood Surg, Norwich NR7 0EF, Norfolk, England

[2] Glaxo Wellcome UK, Uxbridge UB11 1BT, Middx, England

来源：

RESPIRATORY MEDICINE | 1998年 / 92卷 / 11期

关键词：

D O I：

10.1016/S0954-6111(98)90232-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1302 / 1304

页数：3

共 7 条

[1]

*BRIT THOR SOC, 1997, THORAX S1, V52, pS1, DOI DOI 10.1136/THX.52.2008.S1]

[2] ADDED SALMETEROL VERSUS HIGHER-DOSE CORTICOSTEROID IN ASTHMA PATIENTS WITH SYMPTOMS ON EXISTING INHALED CORTICOSTEROID [J].

GREENING, AP ;

IND, PW ;

NORTHFIELD, M ;

SHAW, G .

LANCET, 1994, 344 (8917) :219-224

[3] Issues in the use of inhaled glucocorticoids [J].

Kamada, AK ;

Szefler, SJ ;

Martin, RJ ;

Boushey, HA ;

Chinchilli, VM ;

Drazen, JM ;

Fish, JE ;

Israel, E ;

Lazarus, SC ;

Lemanske, RF ;

Cherniak, RM ;

Hurd, SS ;

Peters, SP ;

Sorkness, C ;

Szefler, SJ ;

Zwillich, CW .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (06) :1739-1748

[4] Fluticasone propionate: an audit of outcomes and cost-effectiveness in primary care [J].

Price, DB ;

Appleby, JL .

RESPIRATORY MEDICINE, 1998, 92 (02) :351-353

[5]

*ROYAL COLL GEN PR, 1995, MORB STAT GEN PRACT

[6]

TAYLOR DR, 1997, AM J RESP CRIT CARE, V155, pA342

[7] Effect of long term treatment with salmeterol on asthma control: A double blind, randomised crossover study [J].

Wilding, P ;

Clark, M ;

Coon, JT ;

Lewis, S ;

Rushton, L ;

Bennett, J ;

Oborne, J ;

Cooper, S ;

Tattersfield, AE .

BRITISH MEDICAL JOURNAL, 1997, 314 (7092) :1441-1446

← 1 →